Background: A mother is the nearest person to a neonate to identify, present and manage the neonates' problem, which ensure that neonate can lead a healthy life. Every year four million babies die in the first month of life and a quarter of these take place in India. About 98% of new-born deaths occur in developing countries, where most new-borns deaths occur at home. The main obstacles in improving new-born survival are that many babies are born at home without skilled attendance. Hence the present study was aimed to assess the attitude and practice of mothers to recognize neonatal danger signs and various household practices followed by mother to identify and to treat danger signs.
Background
Matteuccia struthiopteris (L.) Todaro is a popular edible wild fern found in the subtropical Himalayas. It is widely used in folk medicine to treat several ailments and known for its antioxidant, anti-inflammatory, antibacterial, antiviral and antidiabetic activities. Due to its multidimensional nutritional, pharmacological and therapeutic effects, it is well recognized in the Ayurvedic Pharmacopoeia.
Main body of abstract
The present review aims to provide updated information on Matteuccia struthiopteris botany, phytochemistry, pharmacological effects and toxicity methods, in addition to highlight potential for future exploration. Particular emphasis is also given to its antioxidant potential in health promotion. In-depth literature was probed by examining numerous sources via online databases (research and reviews), texts, Web sites and thesis. Plant biotechnology approaches such as tissue culture and micropropagation are also discussed.
Short conclusion
Matteuccia struthiopteris is found useful in the treatment of different diseases such as microbial infection, viral infection and diabetes and in weight reduction and also effective as antioxidant and free radical scavenger. Nevertheless, advance studies are required to offer the mechanistic role of crude extracts and its bio-actives and even to discover the structure–function relationship of active principles.
The main aim of the study is to assess the effect of progressive muscle relaxation therapy on physical parameter and anxiety among patient with myocardial infarction admitted at selected hospitals of Durg (C.G). The study was conducted at B.M Shah Hopsital and K. Gurunath Cardiac Hospital for patient with myocardial infacrtion.Quasi experimental pretest posttest control group design was adopted for this study. Convenient sampling technique was used to select the study participants. The patient with myocardial infarction was assigned to experimental group (n=23) and the other to the control group (n=23). Progressive muscle relaxation therapy was given for 20 minutes once daily in the morning between 6-8AM for 7 days. Physical parameter and anxiety measurements were taken from the first day and 7 day and was documented. The study showed a significant reduction of physical parameters mean blood pressure from 5.75 to 5.5 mm of Hg, for pulse 5.5 to 5, for respiration 7 to 5.7, and SPO2 7 to 5.8. calculated ‘t’ value was greater than the table value at 0.001 level of significance. Level of anxiety before and after progressive muscle relaxation among the experimental group was 50and 44.5. respectively. Standard deviation was 7.0, 6.6 and the calculated ‘t’ value was 3.4. While comparing with table value, it showed that the calculated ‘t’ value was greater than the table value at 0.001 level of significance.Hence it is concluded that progressive muscle relaxation therapy is an effective measure to maintain the level of physical parameters and reduce the level of anxiety among patient with myocardial infarction at selected hospitals of Durg (C.G).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.